Zimbabwe becomes first African country to approve injectable HIV prevention drug
The Medicines Control Authority of Zimbabwe on Monday announced the approval of the use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) for HIV prevention, a first for Africa. Zimbabwe has become the first country in Africa to approve a